Showing results (181-190 of 324) with videos related to
Sort By:
Pageof 33
Oncotarget|April 23, 2016
Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinomaFei Zhang, Peng Sun, Zhi-Qiang Wang, et al.Plos One|August 23, 2012
Are risk factors associated with outcomes in pancreatic cancer?De-shen Wang, Zhi-qiang Wang, Le Zhang, et al.Journal of Translational Medicine|November 3, 2010
Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinomaMiao-Zhen Qiu, Zhuang-Hua Li, Zhi-Wei Zhou, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 4, 2010
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapyXin An, Pei-Rong Ding, Xiao-Juan Xiang, et al.Cancer Chemotherapy and Pharmacology|January 4, 2008
Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinomaYu-Hong Li, Feng-Hua Wang, Wen-Qi Jiang, et al.Environmental Monitoring and Assessment|August 8, 2024
Mechanisms for carbon stock driving and scenario modeling in typical mountainous watersheds of northeastern ChinaJin Zhang, Wen-Guang Zhang, Xin-Yan Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2010
EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patientsYu-Hong Li, Fang Wang, Lin Shen, et al.Oncotarget|June 27, 2016
Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 casesYun Wang, Zhi-Qiang Wang, Feng-Hua Wang, et al.International Journal of Surgery (London, England)|March 27, 2025
Long-term efficacy and progression patterns of paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced, borderline-resectable esophageal squamous cell carcinoma: results from a phase II NEOCRTEC1601 studyJia-Di Wu, Zhi-Qiang Wang, Qiao-Qiao Li, et al.Chinese Journal of Cancer|January 8, 2016
Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancerZhi-Qiang Wang, Dong-Sheng Zhang, Nong Xu, et al.Pageof 33